Results 1 - 20 of 402 for All Library Resources
Show only
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Standards
|
|
3C Patch for treating diabetic foot ulcersNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 2 |
Material Type: Standards
|
|
Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrenceNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 3 |
Material Type: Standards
|
|
Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapyNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 4 |
Material Type: Standards
|
|
Abrocitinib, tralokinumab or upadacitinib for treating moderate to severe atopic dermatitisNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 5 |
Material Type: Standards
|
|
Acalabrutinib for treating chronic lymphocytic leukaemiaNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 6 |
Material Type: Standards
|
|
Adalimumab and dexamethasone for treating non-infectious uveitisNICE Guidance, 2017Copyrights: © NICE 2017 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 7 |
Material Type: Standards
|
|
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young peopleNICE Guidance, 2017Copyrights: © NICE 2017 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 8 |
Material Type: Standards
|
|
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failedNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 9 |
Material Type: Standards
|
|
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan INICE Guidance, 2018Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 10 |
Material Type: Standards
|
|
Afamelanotide for treating erythropoietic protoporphyriaNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 11 |
Material Type: Standards
|
|
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusionNICE Guidance, 2016Copyrights: © NICE 2016 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 12 |
Material Type: Standards
|
|
AI-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan imagesNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 13 |
Material Type: Standards
|
|
Air pollution: outdoor air quality and healthNICE Guidance, 2017Copyrights: © NICE 2017 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 14 |
Material Type: Standards
|
|
Alectinib for untreated ALK-positive advanced non-small-cell lung cancerNICE Guidance, 2018Copyrights: © NICE 2018 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 15 |
Material Type: Standards
|
|
Alpelisib with fulvestrant for treating hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancerNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 16 |
Material Type: Standards
|
|
Amivantamab for treating EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapyNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 17 |
Material Type: Standards
|
|
Anakinra for treating Still’s diseaseNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 18 |
Material Type: Standards
|
|
Andexanet alfa for reversing anticoagulation from apixaban or rivaroxabanNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 19 |
Material Type: Standards
|
|
Apremilast for treating active psoriatic arthritisNICE Guidance, 2017Copyrights: © NICE 2017 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
| 20 |
Material Type: Standards
|
|
Apremilast for treating moderate to severe plaque psoriasisNICE Guidance, 2016Copyrights: © NICE 2016 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
Results 1 - 20 of 402 for All Library Resources
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 2016 (2)
- 2016 To 2017 (80)
- 2018 To 2019 (79)
- 2020 To 2022 (156)
- After 2022 (86)
-
More options
New Records
Subject
- Clinical Practice Guidelines (376)
- Committees (331)
- Marketing (259)
- Clinical Medicine (162)
- Patients (144)
- Drug Dosages (136)
- Cancer Therapies (132)
- Quality Of Life (130)
- Chemotherapy (129)
- Clinical Trials (103)
- Cost Analysis (92)
- Metastasis (85)
- Palliative Care (63)
- Medical Prognosis (63)
- Decision Making (61)
- Mutation (61)
- Tumors (38)
- Immunotherapy (38)
- Contraindications (36)
- Lung Cancer (33)
-
More options
Databases
- ProQuest Central (401)
- ProQuest One Psychology (400)
- IEEE Open Access Journals (1)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||